✦ LIBER ✦

Subsequent Chemotherapy Improves Survival Outcome in Advanced Non–Small-Cell Lung Cancer With Acquired Tyrosine Kinase Inhibitor Resistance

✍ Scribed by Chih-Hsi Kuo; Shu-Min Lin; Kang-Yun Lee; Fu-Tsai Chung; Meng-Heng Hsieh; Yueh-Fu Fang; Chih-Ten Yu; Han-Pin Kuo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subsequent chemotherapy reverses acquire

✍ Renhua Guo; Xiaofen Chen; Tongshan Wang; Zhiyuan Zhang; Jin Sun; Yongqian Shu 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 307 KB

18 Chemotherapy or tyrosine kinase inhib

✍ Jyoti, B.; McKay, M.; Wong, H.; Alam, F.; Eswar, C.; Jain, P.; Littler, J.A.H.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Clinical modes of EGFR tyrosine kinase i

✍ Yang, Jin-Ji; Chen, Hua-Jun; Yan, Hong-Hong; Zhang, Xu-Chao; Zhou, Qing; Su, Jia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 700 KB

Primary and Acquired Resistance to Epide

✍ Ayoola, Ayodele; Barochia, Amit; Belani, Kiran; Belani, Chandra P. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 403 KB

Metronomic Chemotherapy in Patients with

✍ Nick Chen 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 77 KB

Erlotinib (OSI-774, Tarceva™), a Selecti

✍ Mary Hightower; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 78 KB